


Searching News Database: Fujisawa
HSMN NewsFeed - 10 Jan 2019
Astellas Announces Key Senior Leadership Promotions and New Hire in Medical and Development Organization
Astellas Announces Key Senior Leadership Promotions and New Hire in Medical and Development Organization
HSMN NewsFeed - 3 Apr 2014
EMBL Ventures Invests £2M ($3.3M) in a Second Close of Crescendo Biologics' Series A Financing
EMBL Ventures Invests £2M ($3.3M) in a Second Close of Crescendo Biologics' Series A Financing
HSMN NewsFeed - 23 May 2013
Astellas Receives Marketing Authorization for VESOMNI(TM) from the Netherlands Medicines Evaluation Board
Astellas Receives Marketing Authorization for VESOMNI(TM) from the Netherlands Medicines Evaluation Board
HSMN NewsFeed - 17 Aug 2011
Planet Biopharmaceuticals, Inc. Appoints Theron (Ted) Odlaug, Ph.D. as Executive Chairman
Planet Biopharmaceuticals, Inc. Appoints Theron (Ted) Odlaug, Ph.D. as Executive Chairman
HSMN NewsFeed - 14 Oct 2009
XOMA Appoints Susan Kramer, Dr. P.H. Vice President of Project and Alliance Management
XOMA Appoints Susan Kramer, Dr. P.H. Vice President of Project and Alliance Management
HSMN NewsFeed - 23 Feb 2009
Astellas Pharma Issues Statement Regarding CV Therapeutics Rejection of All-Cash Proposal
Astellas Pharma Issues Statement Regarding CV Therapeutics Rejection of All-Cash Proposal
HSMN NewsFeed - 13 Oct 2008
Theron Odlaug, Ph.D. Promoted to Chief Executive Officer at CyDex Pharmaceuticals
Theron Odlaug, Ph.D. Promoted to Chief Executive Officer at CyDex Pharmaceuticals
HSMN NewsFeed - 22 May 2008
CyDex Pharmaceuticals Appoints Theron (Ted) Odlaug, Ph.D. as President and Chief Operating Officer
CyDex Pharmaceuticals Appoints Theron (Ted) Odlaug, Ph.D. as President and Chief Operating Officer
HSMN NewsFeed - 10 Mar 2008
OREXIGEN(TM) Therapeutics Appoints Carol Baum as Vice President of Commercialization
OREXIGEN(TM) Therapeutics Appoints Carol Baum as Vice President of Commercialization
HSMN NewsFeed - 11 Oct 2007
AkaRx and MGI PHARMA Announce Closing of Development and License Agreement
AkaRx and MGI PHARMA Announce Closing of Development and License Agreement
HSMN NewsFeed - 29 May 2007
DRAXIS Appoints Bruce DeChambre to Head Business Development for Contract Manufacturing Division
DRAXIS Appoints Bruce DeChambre to Head Business Development for Contract Manufacturing Division
HSMN NewsFeed - 26 Jan 2007
Astellas and Pfizer Reached Settlement on Declaratory Judgment Action Relating to Lipitor Agreement
Astellas and Pfizer Reached Settlement on Declaratory Judgment Action Relating to Lipitor Agreement
HSMN NewsFeed - 11 Dec 2006
Advanced Life Sciences Announces Election of Theron (Ted) E. Odlaug, Ph.D. to Its Board of Directors
Advanced Life Sciences Announces Election of Theron (Ted) E. Odlaug, Ph.D. to Its Board of Directors
HSMN NewsFeed - 31 Oct 2006
Jody LoMenzo Named Director, Investor Relations and Corporate Communications
Jody LoMenzo Named Director, Investor Relations and Corporate Communications
HSMN NewsFeed - 26 Oct 2006
Cleveland BioLabs Appoints John Gordon, Ph.D. Director of Clinical Operations
Cleveland BioLabs Appoints John Gordon, Ph.D. Director of Clinical Operations
HSMN NewsFeed - 25 May 2006
Abraxis BioScience Bolsters Manufacturing and Global Operational Expertise With Key Senior Executives
Abraxis BioScience Bolsters Manufacturing and Global Operational Expertise With Key Senior Executives
HSMN NewsFeed - 8 May 2006
Medicis Announces FDA Approval of SOLODYN -- minocycline HCl, USP -- Extended Release Tablets
Medicis Announces FDA Approval of SOLODYN -- minocycline HCl, USP -- Extended Release Tablets
Additional items found! 66
Members Archive contains
66 additional stories matching:
Fujisawa
(Password required)
Fujisawa
(Password required)
